VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |
| Samsara BioCapital, LLC | 347,500 | $5,664,250 | 1.73% |
| 1492 Capital Management LLC | 164,459 | $2,680,682 | 1.73% |
| Affinity Asset Advisors, LLC | 368,329 | $6,003,763 | 1.69% |
| Tri Locum Partners LP | 318,076 | $5,184,639 | 1.66% |
| Nicholas Investment Partners, LP | 1,162,989 | $18,956,721 | 1.42% |
| Caligan Partners LP | 183,064 | $2,983,943 | 1.37% |
| Orbimed Advisors | 3,777,778 | $61,577,781 | 1.31% |
| Parkman Healthcare Partners LLC | 417,933 | $6,812,308 | 1.25% |
| MOODY ALDRICH PARTNERS LLC | 354,837 | $5,783,843 | 1.10% |
| Paradigm Biocapital Advisors LP | 926,432 | $15,100,842 | 1.02% |
External links
This page lists VERONA PHARMA PLC's shareholders in Q3 2023. To view VERONA PHARMA PLC's shareholder history, click here.